My SciELO
Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Española de Enfermedades Digestivas
Print version ISSN 1130-0108
Abstract
NUNEZ-ORTIZ, Andrea et al. Topical mesalazine as a cause of Stevens-Johnson syndrome. Rev. esp. enferm. dig. [online]. 2018, vol.110, n.11, pp.736-738. ISSN 1130-0108. https://dx.doi.org/10.17235/reed.2018.5429/2017.
Mesalazine is a drug routinely used in ulcerative colitis and usually has few side effects. There have been reports of uncommon cases of severe mucocutaneous damage, such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), induced by salicylates. It is important to diagnose these promptly due to the high morbidity and mortality rates. We describe the case of a 46-year-old female with ulcerative proctitis, who developed SJS following topical mesalazine use. The lesions responded well to intravenous corticosteroids after discontinuation of the drug.
Keywords : Mesalazine; Stevens-Johnson syndrome; Toxic epidermal necrolysis.